BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Vitamin E
,
rs6983267
,
TGFB1
,
Fatty acid metabolic process
,
Lung cancer
,
Heart
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
thiosemicarbazones
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Iron chelation in regulation of gene expression in DMS-53 small cell lung carcinoma cells
Primary effusion lymphoma BCP1 cells treated with ribonucleotide reductase inhibitor triapine
Explore Curated Studies Results
Literature
Most Relevant Literature
Desulfurization of thiosemicarbazones: the role of metal ions and biological implications.
A potentiometric and spectrofluorimetric approach to unravel inhibitory effects of semi- and thiosem…
1H-Indole-2,3-dione 3-thiosemicarbazones carrying a 4-sulfamoylphenyl moiety with selective antivira…
Innovative N-Acridine Thiosemicarbazones and Their Zn(II) Complexes Transmetallate with Cu(II): Redo…
Human serum albumin as a copper source for anticancer thiosemicarbazones.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors
Renal Blood Flow Measurement With Positron Emission Tomography (PET)
A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment …
3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors
Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ